Human physiology is the science of the mechanical, physical, and biochemical functions of humans in good health, their organs, and the cells of which they are composed. The principal level of focus of physiology is at the level of organs and systems. Most aspects of human physiology are closely homologous to corresponding aspects of animal physiology, and animal experimentation has provided much of the foundation of physiological knowledge. Anatomy and physiology are closely related fields of study: anatomy, the study of form, and physiology, the study of function, are intrinsically tied and are studied in tandem as part of a medical curriculum.
UCLA has received a five-year, $12.5 million contract award from the National Heart, Lung and Blood Institute to spearhead an international consortium of medical experts that will study proteins that may be involved in the development of cardiovascular disease.
The National Institute of General Medical Sciences (NIGMS) has awarded Albert Einstein College of Medicine of Yeshiva University a five-year, $30 million grant to study the structure and function of thousands of biomedically important proteins.
Tengion, Inc. presented new research data yesterday in a podium presentation at the 2nd Annual Symposium on Stem Cell Translation of the International Society for Cellular Therapy (ISCT) in San Francisco. The presentation highlighted new results from Tengion's Neo-Kidney Augment development program demonstrating success with an autologous cellular therapy approach to kidney regeneration in a rodent model of obesity, diabetes and hypertension.
Alnylam Pharmaceuticals, Inc. a leading RNAi therapeutics company announced today that it has published results in the American Journal of Respiratory and Critical Care Medicine from its double-blind, placebo-controlled, randomized Phase IIa study of ALN-RSV01 in lung transplant patients naturally infected with respiratory syncytial virus (RSV).
A team of researchers led by a Michigan State University scientist has been awarded $14 million to identify risk factors for breast cancer in young women, focusing on growth, diet, physical activity and body size during a woman's lifetime.
Researchers at Stanford University were able to use light to induce normal patterns of muscle contraction, in a study involving bioengineered mice whose nerve-cell surfaces are coated with special light-sensitive proteins.
Researchers in the Midwest are developing microelectronic circuitry to guide the growth of axons in a brain damaged by an exploding bomb, car crash or stroke. The goal is to rewire the brain connectivity and bypass the region damaged by trauma, in order to restore normal behavior and movement.
A five year study monitoring brain activity during therapy sessions uncovered the mystery of “sixth sense” and how two people interact on a physiological level. The study from Sydney revealed how parts of their nervous systems can be aligned despite having no physical contact with each other.
Van Andel Research Institute (VARI) scientists participated in a study with researchers from the University of Utah that could help find ways to improve shunt systems used to treat the neurological disorder hydrocephalus, or "water on the brain," the leading cause of brain surgery for children in the United States. Researchers studied the shunt systems under a variety of conditions by creating a bioreactor that mimics the environment inside patients.
Leading experts in the field of food additive safety and risk communication gathered at a symposium hosted today by the Nutrition Research Foundation at the 2nd World Congress of Public Health Nutrition to discuss the safety of low-calorie sweeteners and reaffirm the positive role they can play in the diet.
The majority of pharmacists across the profession who were involved in a UK study reported the patient's health interests as the most important factor to consider in ethical decision making. They also indicated that regulation seems to play a very important part in moral decision making.
Boston University School of Medicine (BUSM) researchers have been awarded a Small Business Technology Transfer (STTR) phase 1 award to develop and test a newly designed fluorescent lamp that is capable of producing vitamin D in the skin.
TRS Institute (TRSi), the nation's leading provider of AHDI-approved online medical transcription and speech recognition training programs, announces two new courses designed for healthcare documentation professionals, medical transcriptionists, and allied health professionals. The online courses will assist healthcare professionals in honing skills to increase their marketability in the healthcare documentation field.
Topics ranging from the future of addiction research and treatment to the binational implications of Mexico's decriminalization of drugs will be presented at the 10th Annual International Conference of the National Hispanic Science Network (NHSN) on Drug Abuse September 30 - October 2, 2010 at The Westin New Orleans Canal Place.
Although obesity is a major risk factor for disease, much of the threat may be associated with the metabolic (or cardiometabolic) syndrome, a cluster of risk factors related to diabetes and heart disease. Losing weight can improve health and reduce many of these risk factors. However, many people struggle to keep the weight off long-term.
Taking chromium picolinate may help lessen inflammation associated with diabetic nephropathy (kidney disease), say researchers at the Medical College of Georgia in Augusta.
The cellular services company Beta-Pro LLC, announced today that it donated more than 300,000 human pancreatic islet cells to nationally renowned diabetes researcher Raghavendra G. Mirmira, M.D., Ph.D., the Eli Lilly & Co. Professor of Pediatric Diabetes, Indiana University School of Medicine, Herman B.
Cardiac Cath Lab Director is a new bimonthly journal being launched in February 2011 by SAGE, the world's leading independent academic and professional publisher.
With respect to the Symptoms Check List-27, the values of the GSI (Global Severity Index) and of 3 subscales (those for depressive, dysthymic and mistrust symptoms), compared with the control group, improved significantly upon participation in the group program.
Echo Therapeutics, Inc., a company developing its needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude™ SkinPrep System for transdermal drug delivery, today announced that it is beginning a development program designed to create a new transdermal biosensor for continuous lactate monitoring to be used in critical care and sports medicine.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.